Lansoprazole Teva-Ratiopharm (Lansoprazole)

Lansoprazole exerts its effect by irreversibly binding to the H+/K+ ATPase enzyme, commonly known as the gastric proton pump, located on the secretory surface of parietal cells. This inhibition blocks the final step of acid secretion, leading to a marked and sustained reduction in both basal and stimulated gastric acid output, thereby creating a less acidic gastric environment.

The appropriate dosage of Lansoprazole is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function, and treatment duration. Typical regimens may involve once‑daily administration, but the exact strength, frequency, and length of therapy are individualized and should follow the prescriber’s written instructions.

Safety data for Lansoprazole in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case carefully, and breastfeeding mothers should discuss potential exposure with their physician before initiating therapy.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lansoprazole, like other PPIs, inhibits the gastric proton pump, but it may offer a slightly longer duration of acid suppression and a different metabolic profile. Compared with omeprazole, Lansoprazole is less affected by CYP2C19 polymorphisms, which can result in more consistent plasma levels in certain populations. Choice of agent often depends on clinician preference, patient response, and drug‑interaction considerations.

Lansoprazole tablets should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat. Do not store in a refrigerator or freezer unless specifically instructed by the manufacturer.

Lansoprazole is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, often in the morning, to maximize acid‑suppression effect. Patients should follow the prescriber’s instructions regarding timing, whether to take with or without food, and any need for dose adjustments.

Serious risks, though uncommon, include Clostridioides difficile‑associated diarrhea, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, liver enzyme elevations, hypomagnesemia, and an increased risk of bone fractures with long‑term use. Patients should be advised to seek immediate medical attention if they experience severe rash, persistent diarrhea, muscle cramps, or signs of infection.

Lansoprazole is contraindicated in individuals with known hypersensitivity to lansoprazole, other proton pump inhibitors, or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking certain medications that require an acidic environment for absorption, and patients with a history of unexplained fractures or osteoporosis when long‑term therapy is considered.